Urinary Incontinence Treatment Devices Market

Urinary Incontinence Treatment Devices Market (Product: Urethral Slings, Electrical Stimulation Devices, Artificial Urinary Sphincters, and Catheters) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Urinary Incontinence Treatment Devices Market Outlook

  • The global urinary incontinence treatment devices market was valued at US$ 2.7 Bn in 2021
  • The global market is projected to grow at a CAGR of 7.7% from 2022 to 2031
  • The global urinary incontinence treatment devices market is expected to reach more than US$ 5.5 Bn by the end of 2031

Analysts’ Viewpoint on Urinary Incontinence Treatment Devices Market Scenario

The number of people with urinary incontinence is increasing globally. According to a study, more than 60% women have some type of urinary incontinence. Companies are investing significantly in the development and introduction of new urinary incontinence treatment devices in order to provide the best treatment options to patients. Several market players are engaged in the development and launch of new electrical stimulation devices, such as Medtronic plc’s NURO System, for percutaneous tibial nerve stimulation for the treatment of overactive bladder. Numerous companies are offering non-invasive, over-the-counter electrical stimulation devices for incontinence. Therefore, the global urinary incontinence treatment devices market is projected to present significant opportunities for leading players in the next few years. Usage of electrical stimulation devices is increasing, as they are effective for relieving symptoms of all types of urinary incontinence, and the devices are gaining popularity as these are considered safe and effective. Therefore, new developments and technological advancements are expected to drive the global urinary incontinence treatment devices market during the forecast period.

Urinary Incontinence Treatment Devices Market

Urinary Incontinence Treatment Devices Market Introduction

Urinary incontinence is defined as involuntary release of urine due to loss of bladder control. Urinary incontinence devices are used for the treatment of urinary incontinence. Over 500 million people across the globe are affected by the condition and its incidence increases with age. Several factors such as urinary tract infection, weakening of pelvic floor muscles & urethral sphincters, menopause, pregnancy & childbirth, and post radical prostatectomy surgery in men lead to the development of urinary incontinence symptoms.

The global urinary incontinence treatment devices market size is likely to grow at a rapid pace during the forecast period. High prevalence of urinary incontinence and overactive bladder across the globe and technological advancements, such as non-implantable electrical stimulation devices, are projected to propel the global market during the forecast period.

Request a sample to get extensive insights into the Urinary Incontinence Treatment Devices Market

High Prevalence of Urinary Incontinence and Overactive Bladder to Drive Global Market

Urinary incontinence is one of the highly prevalent and largely underreported and under diagnosed urological disorders in the world, affecting millions of people. It has a severe effect on physical, psychological, and emotional health of patients. Women are affected twice as much as men, and the incidence increases with age. Several factors such as weak pelvic floor muscles, urethral sphincters, obesity, pregnancy & childbirth, urinary tract infection, and neurological disorders cause urinary incontinence. Around 200 million people are affected by some form of urinary incontinence or bladder problems. Urinary incontinence and stress urinary incontinence are the most common forms affecting millions of people globally. Therefore, a large patient pool with stress urinary incontinence and overactive bladder symptoms is expected to augment the global urinary incontinence treatment devices market during the forecast period.

Increase in Incidence of Prostate Cancer Fueling Global Market

Patients undergoing radical prostectomy surgery are at a high risk of developing post prostatectomy urinary incontinence. Radical prostectomy surgery, either through radiation or surgical dissection, affects the bladder’s capacity to hold urine or causes spasms that force urine out. Additionally, radical prostectomy surgery adversely affects the nerves that control bladder function, resulting in urinary incontinence. Prostate cancer is the fourth-leading cancer affecting both men and women, and it is the second most common cancer in men followed by lung cancer. Studies have shown that the rate of stress urinary incontinence among men ranges from 2% to 69% after undergoing prostate surgery. This factor is likely to drive the global urinary incontinence treatment devices market during the forecast period.

Request a custom report on Urinary Incontinence Treatment Devices Market

High Success Rate Bolstering Electrical Stimulation Devices Segment

In terms of product, the global urinary incontinence treatment devices market has been classified into urethral slings, electrical stimulation devices, artificial urinary sphincters, and catheters. The urethral slings segment has been bifurcated into female slings and male slings. The electrical stimulation devices segment has been spilt into implantable and non-implantable.

The electrical stimulation devices segment dominated the global urinary incontinence treatment devices market, with a share of around 42% in 2021. The trend is expected to continue during the forecast period. The electrical stimulation devices segment is propelled by rise in the demand for minimally invasive/wearable and non-implantable electrical stimulation devices to strengthen the pelvic floor muscles, high success rates with electrical stimulation devices, and favorable medical reimbursement policies in developed countries for implantable electrical stimulation devices.

Higher Cost of Treatment Devices Driving Urge Urinary Incontinence Segment

Based on incontinence type, the global urinary incontinence treatment devices market has been segregated into stress urinary incontinence, urge urinary incontinence, mixed incontinence, and overflow incontinence. The urge incontinence segment held major share of around 40% of the global market in 2021. The trend is likely to continue during the forecast period. Growth of the segment can be attributed to higher cost of treatment devices, especially implantable electrical stimulation devices, than other treatment devices/methods such as indwelling Foley catheters. Furthermore, analysis of global urinary incontinence treatment devices market trends revealed an increase in incidence of urge incontinence, rise in adoption of electrical stimulation devices for overactive bladder treatment, and new product launches are likely to propel the segment during the forecast period.

Favorable Reimbursement Policies for Medical Devices Augmenting Hospitals Segment

In terms of end-user, the global urinary incontinence treatment devices market has been divided into hospitals, ambulatory surgery centers, clinics, and home use. The hospitals segment held major share of around 60% of the global market in 2021. Growth of the segment can be attributed to increase in the number of surgical procedures for the treatment of all types of urinary incontinence and favorable reimbursement policies for medical devices in most of the developed and developing countries.

Regional Outlook of Global Urinary Incontinence Treatment Devices Market

North America accounted for the largest global urinary incontinence treatment devices market share of around 42% in 2021. Early adoption of technologies, large patient pool of urinary incontinence, and easy availability & lucrative medical reimbursement policies in the U.S. and Canada are attributed to North America’s prominent market share in 2021.

Europe held around 32% share of the global market in 2021. The market in the region grew at a faster growth rate in 2021 owing to high prevalence and increase in incidence of urinary incontinence, surge in adoption of technologically advanced products, large base of medical device companies, and high number of products in pipeline for the treatment of urinary incontinence.

Asia Pacific held larger share of the global urinary incontinence treatment devices market than Latin America and Middle East & Africa. However, the market in Latin America is likely to grow at a faster pace than in Middle East & Africa.

Analysis of Key Players in Global Urinary Incontinence Treatment Devices Market

The urinary incontinence treatment devices market report concludes with the company profiles section, which includes key information about major players in the global urinary incontinence treatment devices market. Leading players in the global urinary incontinence treatment devices market include C. R. Bard, Inc. (Becton, Dickinson and Company), Coloplast Group, Promedon Group, A.M.I. GmbH, Ethicon US, LLC. (Johnson & Johnson), ZSI Surgical Implants S.R.L., Medtronic plc, InControl Medical LLC, Hollister Incorporated, Atlantic Therapeutics Group Ltd., B. Braun Melsungen AG, and Teleflex Incorporated.

Key Developments in Global Urinary Incontinence Treatment Devices Market

  • In December 2021, Caldera Medical had received FDA clearance for DESARA TVez, a device to treat female stress urinary incontinence
  • In May 2020, Rigicon had announced the launch of two new artificial urinary sphincter systems for incontinence treatment. The two devices launched were ContiClassic Artificial Urinary Sphincter and ContiReflex Artificial Urinary Sphincter. These devices are used as implants to treat urinary incontinence.

Each of these players has been profiled in the urinary incontinence treatment devices market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Global Urinary Incontinence Treatment Devices Market Snapshot

Attribute

Detail

Market Size Value in 2021

US$ 2.7 Bn

Market Forecast Value in 2031

More than US$ 5.5 Bn

Growth Rate (CAGR) for 2022-2031

7.7%

Forecast Period

2022–2031

Historical Data Available for

2017–2021

Quantitative Units

US$ Bn for Value

Market Analysis

It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.

Competition Landscape

  • Market share analysis by company (2021)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • Product
    • Urethral Slings
      • Female Slings
      • Male Slings
    • Electrical Stimulation Devices
      • Implantable
      • Non-implantable
    • Artificial Urinary Sphincters
    • Catheters
  • Incontinence Type
    • Stress Urinary Incontinence
    • Urge Urinary Incontinence
    • Mixed Incontinence
    • Overflow Incontinence
  • End-user
    • Hospitals
    • Ambulatory Surgery Centers
    • Clinics
    • Home Use

Regions Covered

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Japan
  • China
  • India
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • C. R. Bard, Inc. (Becton, Dickinson and Company)
  • Coloplast Group
  • Promedon Group
  • A.M.I. GmbH
  • Ethicon US, LLC. (Johnson & Johnson)
  • ZSI Surgical Implants S.R.L.
  • Medtronic plc
  • InControl Medical LLC
  • Hollister Incorporated
  • Atlantic Therapeutics Group Ltd.
  • B. Braun Melsungen AG
  • Teleflex Incorporated

Customization Scope

Available upon request

Pricing

Available upon request

Frequently Asked Questions

How big was the global urinary incontinence treatment devices market in 2021?

The global urinary incontinence treatment devices market was valued at US$ 2.7 Bn in 2021.

How big will be the global urinary incontinence treatment devices market in 2031?

The global urinary incontinence treatment devices market is projected to reach more than US$ 5.5 Bn by 2031.

What is the CAGR of the global urinary incontinence treatment devices market during the forecast period (2022–2031)?

The global urinary incontinence treatment devices market is anticipated to grow at a CAGR of 7.7% from 2022 to 2031.

What is the market share of the leading segment of the global urinary incontinence treatment devices market?

The electrical stimulation devices segment held around 42% share of the global urinary incontinence treatment devices market in 2021.

Which region will account for major share of the global market during the forecast period?

North America is expected to account for major share of the global market during the forecast period.

Who are the prominent players in the global urinary incontinence treatment devices market?

C. R. Bard, Inc. (Becton, Dickinson and Company), Coloplast Group, Promedon Group, A.M.I. GmbH, Ethicon US, LLC. (Johnson & Johnson), ZSI Surgical Implants S.R.L., Medtronic plc, InControl Medical LLC, Hollister Incorporated, Atlantic Therapeutics Group Ltd., B. Braun Melsungen AG, and Teleflex Incorporated.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Urinary Incontinence Treatment Devices Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Product Definition

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Urinary Incontinence Treatment Devices Market Analysis and Forecast, 2017–2031

            4.4.1. Market Revenue Projections (US$ Mn)

    5. Key Insights

        5.1. Technological Advancements

        5.2. Prevalence of Urinary Incontinence, by Key Region

        5.3. Regulatory & Reimbursement Scenario, by Country/Region

        5.4. COVID-19 Impact Analysis

    6. Global Urinary Incontinence Treatment Devices Market Analysis and Forecast, by Product

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Market Value Forecast, by Product, 2017–2031

            6.3.1. Urethral Slings

                6.3.1.1. Female Slings

                6.3.1.2. Male Slings

            6.3.2. Electrical Stimulation Devices

                6.3.2.1. Implantable

                6.3.2.2. Non-implantable

            6.3.3. Artificial Urinary Sphincters

            6.3.4. Catheters

        6.4. Market Attractiveness Analysis, by Product

    7. Global Urinary Incontinence Treatment Devices Market Analysis and Forecast, by Incontinence Type

        7.1. Introduction & Definition

        7.2. Key Findings / Developments

        7.3. Market Value Forecast, by Incontinence Type, 2017–2031

            7.3.1. Stress Urinary Incontinence

            7.3.2. Urge Urinary Incontinence

            7.3.3. Mixed Incontinence

            7.3.4. Overflow Incontinence

        7.4. Market Attractiveness Analysis, by Incontinence Type

    8. Global Urinary Incontinence Treatment Devices Market Analysis and Forecast, by End-user

        8.1. Introduction & Definition

        8.2. Key Findings / Developments

        8.3. Market Value Forecast, by End-user, 2017–2031

            8.3.1. Hospitals

            8.3.2. Ambulatory Surgery Centers

            8.3.3. Clinics

            8.3.4. Home Use

        8.4. Market Attractiveness Analysis, by End-user

    9. Global Urinary Incontinence Treatment Devices Market Analysis and Forecast, by Region

        9.1. Key Findings

        9.2. Market Value Forecast, by Region

            9.2.1. North America

            9.2.2. Europe

            9.2.3. Asia Pacific

            9.2.4. Latin America

            9.2.5. Middle East & Africa

        9.3. Market Attractiveness Analysis, by Region

    10. North America Urinary Incontinence Treatment Devices Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Market Value Forecast, by Product, 2017–2031

            10.2.1. Urethral Slings

                10.2.1.1. Female Slings

                10.2.1.2. Male Slings

            10.2.2. Electrical Stimulation Devices

                10.2.2.1. Implantable

                10.2.2.2. Non-implantable

            10.2.3. Artificial Urinary Sphincters

            10.2.4. Catheters

        10.3. Market Value Forecast, by Incontinence Type, 2017–2031

            10.3.1. Stress Urinary Incontinence

            10.3.2. Urge Urinary Incontinence

            10.3.3. Mixed Incontinence

            10.3.4. Overflow Incontinence

        10.4. Market Value Forecast, by End-user, 2017–2031

            10.4.1. Hospitals

            10.4.2. Ambulatory Surgery Centers

            10.4.3. Clinics

            10.4.4. Home Use

        10.5. Market Value Forecast, by Country, 2017–2031

            10.5.1. U.S.

            10.5.2. Canada

        10.6. Market Attractiveness Analysis

            10.6.1. By Product

            10.6.2. By Incontinence Type

            10.6.3. By End-user

            10.6.4. By Country

    11. Europe Urinary Incontinence Treatment Devices Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast, by Product, 2017–2031

            11.2.1. Urethral Slings

                11.2.1.1. Female Slings

                11.2.1.2. Male Slings

            11.2.2. Electrical Stimulation Devices

                11.2.2.1. Implantable

                11.2.2.2. Non-implantable

            11.2.3. Artificial Urinary Sphincters

            11.2.4. Catheters

        11.3. Market Value Forecast, by Incontinence Type, 2017–2031

            11.3.1. Stress Urinary Incontinence

            11.3.2. Urge Urinary Incontinence

            11.3.3. Mixed Incontinence

            11.3.4. Overflow Incontinence

        11.4. Market Value Forecast, by End-user, 2017–2031

            11.4.1. Hospitals

            11.4.2. Ambulatory Surgery Centers

            11.4.3. Clinics

            11.4.4. Home Use

        11.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            11.5.1. Germany

            11.5.2. U.K.

            11.5.3. France

            11.5.4. Spain

            11.5.5. Italy

            11.5.6. Rest of Europe

        11.6. Market Attractiveness Analysis

            11.6.1. By Product

            11.6.2. By Incontinence Type

            11.6.3. By End-user

            11.6.4. By Country/Sub-region

    12. Asia Pacific Urinary Incontinence Treatment Devices Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Product, 2017–2031

            12.2.1. Urethral Slings

                12.2.1.1. Female Slings

                12.2.1.2. Male Slings

            12.2.2. Electrical Stimulation Devices

                12.2.2.1. Implantable

                12.2.2.2. Non-implantable

            12.2.3. Artificial Urinary Sphincters

            12.2.4. Catheters

        12.3. Market Value Forecast, by Incontinence Type, 2017–2031

            12.3.1. Stress Urinary Incontinence

            12.3.2. Urge Urinary Incontinence

            12.3.3. Mixed Incontinence

            12.3.4. Overflow Incontinence

        12.4. Market Value Forecast, by End-user, 2017–2031

            12.4.1. Hospitals

            12.4.2. Ambulatory Surgery Centers

            12.4.3. Clinics

            12.4.4. Home Use

        12.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            12.5.1. China

            12.5.2. Japan

            12.5.3. India

            12.5.4. Australia & New Zealand

            12.5.5. Rest of Asia Pacific

        12.6. Market Attractiveness Analysis

            12.6.1. By Product

            12.6.2. By Incontinence Type

            12.6.3. By End-user

            12.6.4. By Country/Sub-region

    13. Latin America Urinary Incontinence Treatment Devices Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by Product, 2017–2031

            13.2.1. Urethral Slings

                13.2.1.1. Female Slings

                13.2.1.2. Male Slings

            13.2.2. Electrical Stimulation Devices

                13.2.2.1. Implantable

                13.2.2.2. Non-implantable

            13.2.3. Artificial Urinary Sphincters

            13.2.4. Catheters

        13.3. Market Value Forecast, by Incontinence Type, 2017–2031

            13.3.1. Stress Urinary Incontinence

            13.3.2. Urge Urinary Incontinence

            13.3.3. Mixed Incontinence

            13.3.4. Overflow Incontinence

        13.4. Market Value Forecast, by End-user, 2017–2031

            13.4.1. Hospitals

            13.4.2. Ambulatory Surgery Centers

            13.4.3. Clinics

            13.4.4. Home Use

        13.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            13.5.1. Brazil

            13.5.2. Mexico

            13.5.3. Rest of Latin America

        13.6. Market Attractiveness Analysis

            13.6.1. By Product

            13.6.2. By Incontinence Type

            13.6.3. By End-user

            13.6.4. By Country/Sub-region

    14. Middle East & Africa Urinary Incontinence Treatment Devices Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Market Value Forecast, by Product, 2017–2031

            14.2.1. Urethral Slings

                14.2.1.1. Female Slings

                14.2.1.2. Male Slings

            14.2.2. Electrical Stimulation Devices

                14.2.2.1. Implantable

                14.2.2.2. Non-implantable

            14.2.3. Artificial Urinary Sphincters

            14.2.4. Catheters

        14.3. Market Value Forecast, by Incontinence Type, 2017–2031

            14.3.1. Stress Urinary Incontinence

            14.3.2. Urge Urinary Incontinence

            14.3.3. Mixed Incontinence

            14.3.4. Overflow Incontinence

        14.4. Market Value Forecast, by End-user, 2017–2031

            14.4.1. Hospitals

            14.4.2. Ambulatory Surgery Centers

            14.4.3. Clinics

            14.4.4. Home Use

        14.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            14.5.1. GCC Countries

            14.5.2. South Africa

            14.5.3. Rest of Middle East & Africa

        14.6. Market Attractiveness Analysis

            14.6.1. By Product

            14.6.2. By Incontinence Type

            14.6.3. By End-user

            14.6.4. By Country/Sub-region

    15. Competition Landscape

        15.1. Market Player - Competition Matrix (by tier and size of companies)

        15.2. Market Share Analysis, by Company, 2021

        15.3. Company Profiles

            15.3.1. C. R. Bard, Inc. (Becton, Dickinson and Company)

                15.3.1.1. Company Description

                15.3.1.2. Business Overview

                15.3.1.3. Financial Overview

                15.3.1.4. Strategic Overview

                15.3.1.5. SWOT Analysis

            15.3.2. Coloplast Group

                15.3.2.1. Company Description

                15.3.2.2. Business Overview

                15.3.2.3. Financial Overview

                15.3.2.4. Strategic Overview

                15.3.2.5. SWOT Analysis

            15.3.3. Promedon Group

                15.3.3.1. Company Description

                15.3.3.2. Business Overview

                15.3.3.3. Financial Overview

                15.3.3.4. Strategic Overview

                15.3.3.5. SWOT Analysis

            15.3.4. A.M.I. GmbH

                15.3.4.1. Company Description

                15.3.4.2. Business Overview

                15.3.4.3. Financial Overview

                15.3.4.4. Strategic Overview

                15.3.4.5. SWOT Analysis

            15.3.5. Ethicon US, LLC. (Johnson & Johnson)

                15.3.5.1. Company Description

                15.3.5.2. Business Overview

                15.3.5.3. Financial Overview

                15.3.5.4. Strategic Overview

                15.3.5.5. SWOT Analysis

            15.3.6. ZSI Surgical Implants S.R.L.

                15.3.6.1. Company Description

                15.3.6.2. Business Overview

                15.3.6.3. Financial Overview

                15.3.6.4. Strategic Overview

                15.3.6.5. SWOT Analysis

            15.3.7. Medtronic plc

                15.3.7.1. Company Description

                15.3.7.2. Business Overview

                15.3.7.3. Financial Overview

                15.3.7.4. Strategic Overview

                15.3.7.5. SWOT Analysis

            15.3.8. InControl Medical LLC

                15.3.8.1. Company Description

                15.3.8.2. Business Overview

                15.3.8.3. Financial Overview

                15.3.8.4. Strategic Overview

                15.3.8.5. SWOT Analysis

            15.3.9. Hollister Incorporated

                15.3.9.1. Company Description

                15.3.9.2. Business Overview

                15.3.9.3. Financial Overview

                15.3.9.4. Strategic Overview

                15.3.9.5. SWOT Analysis

            15.3.10. Atlantic Therapeutics Group Ltd.

                15.3.10.1. Company Description

                15.3.10.2. Business Overview

                15.3.10.3. Financial Overview

                15.3.10.4. Strategic Overview

                15.3.10.5. SWOT Analysis

            15.3.11. B. Braun Melsungen AG

                15.3.11.1. Company Description

                15.3.11.2. Business Overview

                15.3.11.3. Financial Overview

                15.3.11.4. Strategic Overview

                15.3.11.5. SWOT Analysis

            15.3.12. Teleflex Incorporated

                15.3.12.1. Company Description

                15.3.12.2. Business Overview

                15.3.12.3. Financial Overview

                15.3.12.4. Strategic Overview

                15.3.12.5. SWOT Analysis

    List of Tables

    Table 01: Global Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Product, 2017–2031

    Table 02: Global Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Incontinence Type, 2017–2031

    Table 03: Global Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by End-user, 2017‒2031

    Table 04: Global Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Region, 2017–2031

    Table 05: North America Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Country, 2017–2031

    Table 06: North America Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Product, 2017–2031

    Table 07: North America Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Incontinence Type, 2017–2031

    Table 08: North America Urinary Incontinence Treatment Devices Market (US$ Mn) Forecast, by End-user, 2017–2031

    Table 09: Europe Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 10: Europe Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Product, 2017–2031

    Table 11: Europe Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Incontinence Type, 2017–2031

    Table 12: Europe Urinary Incontinence Treatment Devices Market (US$ Mn) Forecast, by End-user, 2017–2031

    Table 13: Asia Pacific Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 14: Asia Pacific Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Product, 2017–2031

    Table 15: Asia Pacific Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Incontinence Type, 2017–2031

    Table 16: Asia Pacific Urinary Incontinence Treatment Devices Market (US$ Mn) Forecast, by End-user, 2017–2031

    Table 17: Latin America Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 18: Latin America Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Product, 2017–2031

    Table 19: Latin America Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Incontinence Type, 2017–2031

    Table 20: Latin America Urinary Incontinence Treatment Devices Market (US$ Mn) Forecast, by End-user, 2017–2031

    Table 21: Middle East & Africa Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 22: Middle East & Africa Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Product, 2017–2031

    Table 23: Middle East & Africa Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Incontinence Type, 2017–2031

    Table 24: Middle East & Africa Urinary Incontinence Treatment Devices Market (US$ Mn) Forecast, by End-user, 2017–2031

    List of Figures

    Figure 01: Global Urinary Incontinence Treatment Devices Market, by Product, 2021 and 2031

    Figure 02: Global Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Product, 2022–2031

    Figure 03: Global Urinary Incontinence Treatment Devices Market (US$ Mn), by Urethral Slings, 2017–2031

    Figure 04: Global Urinary Incontinence Treatment Devices Market (US$ Mn), by Electrical Stimulation Devices, 2017–2031

    Figure 05: Global Urinary Incontinence Treatment Devices Market (US$ Mn), by Artificial Urinary Sphincters, 2017–2031

    Figure 06: Global Urinary Incontinence Treatment Devices Market (US$ Mn), by Catheters, 2017–2031

    Figure 07: Global Urinary Incontinence Treatment Devices Market, by Incontinence Type, 2021 and 2031

    Figure 08: Global Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Incontinence Type, 2022–2031

    Figure 09: Global Urinary Incontinence Treatment Devices Market (US$ Mn), by Stress Urinary Incontinence, 2017–2031

    Figure 10: Global Urinary Incontinence Treatment Devices Market (US$ Mn), by Urge Urinary Incontinence, 2017–2031

    Figure 11: Global Urinary Incontinence Treatment Devices Market (US$ Mn), by Mixed Incontinence, 2017–2031

    Figure 12: Global Urinary Incontinence Treatment Devices Market (US$ Mn), by Overflow Incontinence, 2017–2031

    Figure 13: Global Urinary Incontinence Treatment Devices Market, by End-user, 2021 and 2031

    Figure 14: Global Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 15: Global Urinary Incontinence Treatment Devices Market (US$ Mn), by Hospitals, 2017–2031

    Figure 16: Global Urinary Incontinence Treatment Devices Market (US$ Mn), by Ambulatory Surgery Centers, 2017–2031

    Figure 17: Global Urinary Incontinence Treatment Devices Market (US$ Mn), by Clinics, 2017–2031

    Figure 18: Global Urinary Incontinence Treatment Devices Market (US$ Mn), by Home Use, 2017–2031

    Figure 19: Global Urinary Incontinence Treatment Devices Market Value Share Analysis, by Region, 2021 and 2031

    Figure 20: Global Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Region, 2022–2031

    Figure 21: North America Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, 2017–2031

    Figure 22: North America Urinary Incontinence Treatment Devices Market Value Share Analysis, by Country, 2021 and 2031

    Figure 23: North America Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Country, 2022–2031 

    Figure 24: North America Urinary Incontinence Treatment Devices Market, by Product, 2021 and 2031

    Figure 25: North America Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Product, 2022–2031

    Figure 26: North America Urinary Incontinence Treatment Devices Market, by Incontinence Type, 2021 and 2031

    Figure 27: North America Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Incontinence Type, 2022–2031

    Figure 28: North America Urinary Incontinence Treatment Devices Market, by End-user, 2021 and 2031

    Figure 29: North America Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 30: Europe Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, 2017–2031

    Figure 31: Europe Urinary Incontinence Treatment Devices Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

    Figure 32: Europe Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Country/Sub-region, 2022–2031 

    Figure 33: Europe Urinary Incontinence Treatment Devices Market, by Product, 2021 and 2031

    Figure 34: Europe Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Product, 2022–2031

    Figure 35: Europe Urinary Incontinence Treatment Devices Market, by Incontinence Type, 2021 and 2031

    Figure 36: Europe Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Incontinence Type, 2022–2031

    Figure 37: Europe Urinary Incontinence Treatment Devices Market, by End-user, 2021 and 2031

    Figure 38: Europe Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 39: Asia Pacific Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, 2017–2031

    Figure 40: Asia Pacific Urinary Incontinence Treatment Devices Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

    Figure 41: Asia Pacific Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Country/Sub-region, 2022–2031 

    Figure 42: Asia Pacific Urinary Incontinence Treatment Devices Market, by Product, 2021 and 2031

    Figure 43: Asia Pacific Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Product, 2022–2031

    Figure 44: Asia Pacific Urinary Incontinence Treatment Devices Market, by Incontinence Type, 2021 and 2031

    Figure 45: Asia Pacific Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Incontinence Type, 2022–2031

    Figure 46: Asia Pacific Urinary Incontinence Treatment Devices Market, by End-user, 2021 and 2031

    Figure 47: Asia Pacific Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 48: Latin America Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, 2017–2031

    Figure 49: Latin America Urinary Incontinence Treatment Devices Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

    Figure 50: Latin America Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Country/Sub-region, 2022–2031 

    Figure 51: Latin America Urinary Incontinence Treatment Devices Market, by Product, 2021 and 2031

    Figure 52: Latin America Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Product, 2022–2031

    Figure 53: Latin America Urinary Incontinence Treatment Devices Market, by Incontinence Type, 2021 and 2031

    Figure 54: Latin America Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Incontinence Type, 2022–2031

    Figure 55: Latin America Urinary Incontinence Treatment Devices Market, by End-user, 2021 and 2031

    Figure 56: Latin America Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 57: Middle East & Africa Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, 2017–2031

    Figure 58: Middle East & Africa Urinary Incontinence Treatment Devices Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

    Figure 59: Middle East & Africa Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Country/Sub-region, 2022–2031 

    Figure 60: Middle East & Africa Urinary Incontinence Treatment Devices Market, by Product, 2021 and 2031

    Figure 61: Middle East & Africa Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Product, 2022–2031

    Figure 62: Middle East & Africa Urinary Incontinence Treatment Devices Market, by Incontinence Type, 2021 and 2031

    Figure 63: Middle East & Africa Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by Incontinence Type, 2022–2031

    Figure 64: Middle East & Africa Urinary Incontinence Treatment Devices Market, by End-user, 2021 and 2031

    Figure 65: Middle East & Africa Urinary Incontinence Treatment Devices Market Attractiveness Analysis, by End-user, 2022–2031

     

Copyright © Transparency Market Research, Inc. All Rights reserved